Related Experiment Video
Updated: Jan 22, 2026
04:20
Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
6.2K
Relationship Between Exercise Oscillatory Ventilation Loop and Prognosis of Heart Failure
Taisuke Nakade1, Hitoshi Adachi1, Makoto Murata1
1Department of Cardiology, Gunma Prefectural Cardiovascular Center.
Summary
Exercise oscillatory ventilation (EOV) loop size predicts cardiovascular death in heart failure patients. Larger EOV loop size and lower hemoglobin levels are associated with increased mortality risk.
Area of Science:
- Cardiology
- Pulmonology
- Exercise Physiology
Background:
- Cardiopulmonary exercise testing (CPX) assesses disease severity in cardiac patients.
- Exercise oscillatory ventilation (EOV) is a phenomenon observed during CPX, but its prognostic value in heart failure (HF) is understudied.
- EOV severity can be quantified using end-tidal CO2 pressure and ventilation patterns.
Purpose of the Study:
- To evaluate the association between EOV severity and prognosis in patients with heart failure with reduced ejection fraction (HFrEF).
- To determine if EOV severity predicts cardiovascular death in HFrEF patients.
Main Methods:
- Retrospective analysis of 2,043 patients undergoing CPX.
- Inclusion of 70 HFrEF patients with EOV.
- Median follow-up of 4.3 years with cardiovascular death as the endpoint.
Main Results:
- 48% of participants (34/70) died during follow-up.
- Deceased patients had significantly larger EOV loop size (17.3±7.0 cm² vs. 12.8±6.1 cm², P<0.001).
- Lower hemoglobin (Hb) levels were also observed in patients who died (12.2±1.2 g/dL vs. 13.2±2.9 g/dL, P=0.004).
Conclusions:
- EOV loop size is a significant predictor of cardiovascular death in HFrEF patients.
- Both EOV loop size and Hb levels are independent predictors of mortality in this population.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
790
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
790
01:17Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
01:27Heart Failure I: Introduction
729
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
729
01:22Heart Failure VI: Adjunct Therapies
278
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
278
01:22Heart Failure Drugs: Diuretics
825
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
825
01:30Heart Failure V: Medical Management
227
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227